H.R. 124

119th Congress

In Committee

Byron Nash Renal Medullary Carcinoma Awareness Act of 2023

Sponsored byDemocrat:Rep. Green, Al [D-TX-9]TX· Introduced 3 January 2025
Open on Congress.gov

0

Cosponsors

3

Actions

0

Amendments

0

Committees

—

Since introduced

Introduced
Committee
Passed Chamber
Passed Both
Enacted
Step 1 of 0
Latest action

Referred to the House Committee on Energy and Commerce.

3 January 2025·1 year ago

Summary

Introduced in House · Updated 18 March 2025

Byron Nash Renal Medullary Carcinoma Awareness Act of 2023 [sic]

This bill allows states to receive federal payment under Medicaid for 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. (Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.)

Timeline

3 actions

  1. Referred to the House Committee on Energy and Commerce.

    3 January 2025 · IntroReferral

  2. Introduced in House

    3 January 2025 · IntroReferral

  3. Introduced in House

    3 January 2025 · IntroReferral

Sponsorship

0 cosponsors

Sponsor

Democrat:Rep. Green, Al [D-TX-9]TX

Classification

Policy area

Health

Legislative subjects

CancerDigestive and metabolic diseasesHealth promotion and preventive careMedicaid
Pelosi Tracker
Follow on XJoin our Discord
PoliticiansBillsPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.